grantGrants.gov

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

Organization National Institutes of HealthPosted 31 Oct 2024Deadline 2 Jun 2027
HHS-NIH1193.39393.12193.21393.31393.866synopsis
Sign up free to applyFree account · Full description · Apply link · All opportunity types

Full Description

Opportunity Number: PAR-25-211 Document Type: synopsis CFDA Numbers: 93.393, 93.121, 93.213, 93.313, 93.866

Read the full description

Sign up freeFree account · No credit card required
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) — National Institutes of Health | Dev Procure